ReviewInternational journal of molecular sciences2019

Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges.

Ziyi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.